Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 1 day agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 3 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 22 hours agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 3 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 1 day agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
Chiefs TE Travis Kelce, Social Media Sensation Livvy Dunne Star in New Commercial: ‘Making...
MSN News· 22 hours agoKansas City Chiefs All-Pro tight end Travis Kelce has been in the news for off-field reasons plenty...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...